Tag | Content |
---|
EnhancerAtlas ID | HS046-00235 |
Organism | Homo sapiens |
Tissue/cell | Fetal_muscle_leg |
Coordinate | chr1:11967400-11970420 |
SNPs | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Nkx3-2 | MA0122.3 | chr1:11968331-11968344 | TTTAAGTGTTTTA | - | 6.33 | ZNF143 | MA0088.2 | chr1:11967995-11968011 | TACCCACAATGCATTG | + | 9.63 | ZNF143 | MA0088.2 | chr1:11970183-11970199 | CAATGCATTGTGGGTA | - | 9.63 | Zfx | MA0146.2 | chr1:11969285-11969299 | GAGGCCGAGGCGGG | - | 6.01 |
|
| Number of super-enhancer constituents: 23 | ID | Coordinate | Tissue/cell |
SE_04401 | chr1:11967802-11970392 | Brain_Anterior_Caudate | SE_05426 | chr1:11967459-11970702 | Brain_Cingulate_Gyrus | SE_06308 | chr1:11966827-11970789 | Brain_Hippocampus_Middle | SE_07453 | chr1:11967402-11970810 | Brain_Hippocampus_Middle_150 | SE_08423 | chr1:11967438-11970628 | Brain_Inferior_Temporal_Lobe | SE_10739 | chr1:11967490-11970531 | CD19_Primary | SE_13010 | chr1:11967686-11969397 | CD34_Primary_RO01480 | SE_13010 | chr1:11969509-11970356 | CD34_Primary_RO01480 | SE_13630 | chr1:11967645-11970731 | CD34_Primary_RO01536 | SE_14236 | chr1:11967710-11969205 | CD34_Primary_RO01549 | SE_14236 | chr1:11969377-11970343 | CD34_Primary_RO01549 | SE_14675 | chr1:11967367-11971255 | CD4_Memory_Primary_7pool | SE_16078 | chr1:11967699-11970381 | CD4_Naive_Primary_7pool | SE_16518 | chr1:11967714-11970388 | CD4_Naive_Primary_8pool | SE_21206 | chr1:11967365-11970416 | CD8_Memory_7pool | SE_21842 | chr1:11967413-11970668 | CD8_Naive_7pool | SE_22216 | chr1:11967346-11970790 | CD8_Naive_8pool | SE_34570 | chr1:11966817-11970548 | HCT-116 | SE_40308 | chr1:11967553-11971272 | K562 | SE_54351 | chr1:11967622-11970499 | Spleen | SE_66899 | chr1:11967081-11970418 | H2171 | SE_67244 | chr1:11967631-11970544 | MM1S | SE_67657 | chr1:11967812-11970390 | u87 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr1 | 11968510 | 11969143 | chr1 | 11967830 | 11968200 |
|
Enhancer Sequence | TTCCCCTGCT CAGCCAGTAA TCTGTCTCCC AAACTCCTCA CTCTCCATAT TTCAGGCACA 60 ACAGTTGCCA ACAGAGGTTC TCAATGTGGC CTCCATCAGA ATCACACGGA GGATGAGTTC 120 AGACTCAGGG GGCTGGGCCC AATCCCCAGG CCTGCAGTAG GTCTGGAGTG GCTAGAAGTG 180 TAAGAATTTT TTTTTGGAGA CACGCTCTCG TTATGTTGCC CAGGCTGGTC TTGAACCCCT 240 AGTTCAGGCG ATCAGCCTGC CTCAGCCACC CAAAGTGCTG GGATTACAAG GGTGAGCCAC 300 GGAGTCCAGC CAAGATAATT TTTTTTTTAC TTTTTTTTTT AAGTTCAAAA AAATTCTTTA 360 CTTATTAGGC TAATTGTGCA ATTAAAAAAA AAAAAAAATT GCAAAAACCG CAATTACTTT 420 TGCACCGATC TAATAGCTCG CCCACTGTAA GTAAAGCAGG TAAAGTCAGC CTTTTTCTTC 480 TGGGACCAGA CTCTGCTCTG CCCCGCGGTG GTGGCCTCAG GCGCAGCGCT AAAACGCATG 540 AACCATTTAA GGTATTTCCT GAAACTGGAG CGTGATTGGT GAGACTTTAT TTGCATACCC 600 ACAATGCATT GCGCACTAAA TAATGTTCGT CTTTAAAATT ATTTCCCCTT TTTCCTTCAA 660 CATATCTTTC TCGGAACCGA GATTGCTGTC CCAGAATTGT CTGAAGAAAA AGGCTGAAGT 720 CAATAGCTCT TTTGGGCCGA AGGAAAGTTA CCATTACCCG TTTAGGAGTA GCCGTTACCT 780 GAGAACTGTA GTGTCGACGA CTGATGTTAT ACTCTGGTTT CTCTTCAAAT CGTATAAATC 840 TTTCGCCTTT TACTAAAGAT TTCCGTGGAG AGAAACGAGT GTGAGTCTGA AACCAATTTT 900 TTGAGGCCTT GCGTTTCTTA GCAGGGCTTA TTTTAAGTGT TTTAAAAACA GATGCGATTC 960 CGTTAAATCG CGTGTGGAGC TATGTAAAGT GTATTATAGA ACAAATGCGA GTTACGGTTT 1020 TTCAGCTTTT CGCTTTGTTA AGGTATGTGA TATCAATTGT ATTGCATTTC TGAGCAGTTA 1080 TAATATTAAG ATGTTGGGGT GGCTTACTGC TTTTGACCAA GAAGTAGGGT TTGTTGGTTG 1140 ATTACACCAG TGGTTTTTAA CCCCAGCCAC TGAGTGATGG AGGGTTACCG ACTCACAAGC 1200 GAGCATTAAC GCCTGAGGTC CGCCTGCTGT CAGGGCAGCA AGGCATCAGA TTCTCCTAGG 1260 AGCGGGAACC CTATTGTGAA CTGCGTATAC GAGGTATCTA GGTGCGTGCT CCTTTTAAGA 1320 ATCTAATGGC TGATGACGAG GGGCACAGTT TCAACCTGGA ACTGTCCACA CCCCCTACCC 1380 ACCTTCCCCC GCCCTTGGAA AAACTGCCTT CCATGAACTG GGTCCCTTGT GCCAGAAAGG 1440 TTGGGGACCG CTGGACTATC CGATCAAATG AAGCAGGGAC TCGGGGCGAG CTCCCCCGCT 1500 GCTCCCGCCG GCTTCTCCGT GTAGAATCGA AGAAGGCAGT CCCAAGGGCT CTTCTGCCCC 1560 GTATCCCCGC CTGAGGAGCG TGCCAGGCGC GCAGCTAGTC CTCCCCCGAC CCAACCGGTT 1620 TGATGAAACG CAAGAGAAAG TGAATTTTCC AGCCACTCCC ATTGGCCAGA ATTCGTCTCA 1680 GCCGCAAGGG AGGCTGGGAA GTGCAGTCAT GCCTTCAGGT AGCCGTGAGC CCTGCTAGCG 1740 ATAGGAGATT CTAGAGAGAG GTTGAGTACT GGGGAGGAAA AACTAGCAGG GTCTGTCCCA 1800 GTAAAGGAGG GAGGAAATCC ATCGCAAAAA ATCCTGACCC CCAGGCCGGG CGCGGTGGCT 1860 CACGCCTGTA ATCCCAGCAC TTTGGGAGGC CGAGGCGGGC GGATCACCTG CGGATCACCT 1920 GAGGTCAGGA GTTCGAGACT GGCCTGGCCA ACATGGAGAA ACCCCGTCTC TACTAAAAAT 1980 ACAAAAATTA GCCGGGCAGG AGGGCGCATG CCTGTAATCA CAGCCACTCG GGAGGCTGAG 2040 GCAGGAGAAT CGCTTGAACC TGGAAGGCGG AGGTTGCAGT GAACCGAGAT CGCGCCACTG 2100 CACTCGATCC TGAGCGACAG AGCGAGACTC TGTCTCAAAA AAAAAAAAAA AAAAAAAAAA 2160 AAATCTACCC CGGGCTCAGG CCCTGAAGCA GCCGCCCACA GCCCAGCCCC GCCGTGCCCC 2220 GCCGTGCCCC GCCGTGCCCC GCCGTGCCCC GCCATGCGAC TCAAAGCCCC ATTCAAGCTA 2280 CGTAGGAGGG TAAATTGTCC TTTTCCCCCA AGGCCAGCTG CTCCTCCAGA AGCCAGCTCT 2340 GGTCCTTCAG ACTCAAATAC TAGGGAACAA TGTTTTCTCT GAGTTTTGAG TGTGTTTCTT 2400 GTTTCAGAGT AAATACGAAC CGTCGTAATG GCTAAGGGCA TCTACTTTTA AAACGCTCAA 2460 ATAAGCCTTG CTAAAAAATG CAAGACCTCT AAAAAATTGG TTTAAAACTC AGAATTATTC 2520 CTCTCCACGG AAATCTTTAG TAAAAGGCGA AAGATTTATG CGATATGAAG AGAAACTAGA 2580 GTAAGAACTT CGATGAGTGG CACTCAGTTC TCAGGTAATG GCTACTCCCA ACAGGCTAAT 2640 GGTAAATTTC TTTCTGCCCA AAAGAGCTAT TGACTTCTGC CTTTTTCTTC AGACAATTCT 2700 GGAACAGCAA TCTCAGTTTC AGGAAAGATA GATTGAAGGA AAAAGGGGAC TAGTAATTTT 2760 AAAGACGAAA ATTATTTGGT GCACAATGCA TTGTGGGTAT GCAAATAAAG TCTCAGCAAT 2820 CAAGCTCCAA TTTTGACAAA CTGGTGAAGC CTTAGGGACT CCTCAAAAAA AGGTTTTCTG 2880 TTGCTTTTGT TTTGTCTTAA ATTTCTGATT TTTAATGTTT GTGGGTACAT AGCATGTGTA 2940 TGTATGGGTT ACATGACAAG AGAAAGGTTT TGTTTGTTTG AGATGGAGTC TTGCTCTTGT 3000 CACCCAGGCT GGAGTGCTGT 3020
|